The report focuses its recommendations on pancreatic ductal adenocarcinoma
, which accounts for approximately 95 percent of all pancreatic cancer cases.
1,2) At variance with the fast proliferating and deadly pancreatic ductal adenocarcinoma
, the typical PEN grows slowly and impairs patient quality of life only very late in the course of the disease, even when metastatic.
The study is expected to enroll approximately 124 patients with stage IV pancreatic ductal adenocarcinoma
In addition, STK11/LKB1 gene inactivation is more frequently seen in sporadic IPMNs than it is in conventional ductal adenocarcinoma
It is now recognized that in the pancreas, ductal adenocarcinoma
develops through a stepwise tumor progression model analogous to the adenoma-carcinoma sequence in the colorectum, in which consecutive preinvasive stages are relatively well defined and morphologically distinctive (Figure 1).
This could ultimately lead to a simple, highly sensitive diagnostic assay for the early detection of pancreatic ductal adenocarcinoma
This study enrolled 28 patients with stage IV treatment naE[macron]ve pancreatic ductal adenocarcinoma
The major difficulty in the differential diagnosis of chronic pancreatitis (CP) is distinguishing it from pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma
(PDAC or pancreatic cancer) is a leading cause of cancer-related mortality worldwide primarily due in part to late stage diagnosis stemming from the lack of an early diagnostic screening tool.
2) There also is frequent clinical and radiologic overlap between chronic pancreatitis and ductal adenocarcinoma
miRInform[R] Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma
(PDAC) when cytology is inconclusive.
Additional Study Details In the study, 28 stage IV treatment naE[macron]ve pancreatic ductal adenocarcinoma
patients with primary tumor located at head, body and tail were enrolled.